Foxevans1725

Protected areas in Western Australia are a significant resource base for nature-based tourism and recreation. Visitor incidents are of special interest to managers of these areas because of concerns regarding public safety. The ongoing monitoring and analysis of visitor incidents plays a major role in reducing incident occurrence.

Incident data recorded by the Parks and Wildlife Service from July 2011 to June 2017 were analyzed for an overview of trends and patterns of incident occurrence. For parks with the highest incident frequency, the level of risk experienced by visitors, combining incident probability and severity, was determined.

A total of 459 visitor incidents were recorded, 77±11 per year. Minor incidents accounted for 48% of incidents, 43% were major, and 8% were fatal. Trip/Slip incidents were most frequent. Fatalities were mostly falls from a height or water-related incidents. Karijini National Park (highest number of incidents) and Ningaloo (highest number of fatalities) were identified as priority areas for managing visitor risk. The greatest individual visitor risk values were calculated for Mitchell River and Karijini national parks.

Recreational injuries are of great concern to the Parks and Wildlife Service in Western Australia. Quantifying and categorizing visitor incidents helps in understanding the trends and patterns of incident occurrence in protected areas, and priority areas for targeted visitor risk management intervention can be identified.

Recreational injuries are of great concern to the Parks and Wildlife Service in Western Australia. Quantifying and categorizing visitor incidents helps in understanding the trends and patterns of incident occurrence in protected areas, and priority areas for targeted visitor risk management intervention can be identified.

The objective of this work was to make a review of urinary tract symptoms and erectile dysfunction involved in obstructive sleep apnea (OSA) but also to study their physiopathology and potential treatments.

We conducted a literature review in the Pubmed database using PRISMA guidelines and the MeSH terms sleep apnea, urinary incontinence, erectile dysfunction, sexuality. All French and English articles published up to 2020 were evaluated.

The initial evaluation identified 240 articles from which 30 were included. References lists review allowed the inclusion of 26 additional articles. Nocturia, overactive bladder (OAB) and erectile dysfunction (ED) were associated with OSA. Increased levels of natriuretic peptides are behind nocturia. Nocturia is associated with higher Apnea/Hypopnea Index (AHI) (49±11 vs 24±8 episodes/hour with P=0.0001). The severity of nocturia is proportional to the severity of OSA with a positive predictive value of 71%. Intermittent nocturnal hypoxemia causes peripheral axonal damry tract symptoms (nocturia and OAB) and erectile dysfunction. The severity of associated symptoms is related to the severity of OSA. Urinary and sexual troubles are reversible after treatment of OSA by CPAP. OSA research is reasonable in case of pathologic nocturia or ED with loss of morning erections.

Several recent publications, including an expert summary on hyperkalemia management, have encouraged plant-based foods for patients with chronic kidney disease (CKD) and highlighted the impact of potassium additives on total potassium intake. The aim of this research brief was to investigate if and/or how current recommendations for low-potassium diet may incorporate these new recommendations.

Using a geographical approach, each province's and territory's government health and renal program (where applicable) website was reviewed for resources on dietary potassium restriction. All handouts/booklets/printable webpages were obtained and reviewed.

Eighteen resources from 6 provincial health agencies in Canada were included. Six additional resources from national agencies were also included, 4 from Canada and 2 from the United States. The 5 most commonly restricted foods were bananas, potatoes, oranges, cantaloupe, and avocados. All resources recommended restriction of fruits and vegetables, 67% recommendedew recommendations differ from current teaching materials that predominately restrict plant-based foods to manage hyperkalemia in CKD. Updates will likely be needed to current resources to reflect new recommendations.

The Shoulder Pain and Disability Index (SPADI) is a simple disease specific questionnaire that is used to evaluate the impact of shoulder disorders. The purpose of this study was to translate the SPADI into Japanese (SPADI-Jp) and evaluate its reliability and validity in Japanese patients with shoulder disorders.

Cross-cultural adaptation of the SPADI was performed according to international guidelines. A total of 100 patients with shoulder disorders participated in this study. Each participant was asked to finish the SPADI-Jp, Disability of Arm, Shoulder and Hand (DASH), and the Short-Form 36 (SF-36) at the initial visit. Thirty-four patients repeated the SPADI-Jp to assess the test-retest reliability. The test-retest reliability was quantified using the interclass correlation coefficient (ICC), while Cronbach's alpha was calculated to assess the internal consistency. Selleck BAY 1000394 The construct validity was assessed using Spearman's rank correlation coefficients.

Internal consistency in the SPADI-Jp was very high (nese population.

The effective reduction of LDL-C in patients with heterozygous familial hypercholesterolemia (HeFH) is crucial to reduce their increased cardiovascular risk. Diagnostic and therapeutic (PCSK9 inhibitors) tools to manage HeFH improved in recent years. However, the impact of these progresses in ameliorating the contemporary real-world care of these patients remains to be determined. Aim of this study was to assess the evolution of treatments and LDL-C control in a cohort of HeFH patients in Italy.

Four hundred six clinically diagnosed HeFH followed in a single, tertiary lipid centre were included in this survey. Data on lipid levels and medications were collected at baseline and during a median 3-year follow-up. At baseline, 19.8% of patients were receiving conventional high-potency lipid lowering therapies (LLT) and this percentage increased up to 50.8% at last visit. The knowledge of results of molecular diagnosis was associated with a significant increase in treatment intensity and LDL-C lowering. Nevertheless, the new LDL-C target (<70mg/dl) was achieved only in 3.